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ABSTRACT
A rapid  and sustained  increase  in  the  number of microbodies in  liver and  kidney cells can
be induced  in male rats by ethyl chlorophenoxyisobutyrate  (CPIB),  a hypolipidemic  drug.
This  phenomenon permits  investigation  of several aspects of microbody  behavior in experi-
mental  conditions.  Reversal  experiments  demonstrate  that  liver  cells  revert  to  normal
between  2 and  3 weeks after  withdrawal  of CPIB and  that one  of the mechanisms  for  re-
moval  of  excess  microbodies  is  their  incorporation  into  structures  indistinguishable  from
lysosomes.  In a  state  of rapid cell  division,  such  as  that  present  during liver  regeneration,
microbody  proliferation  apparently  occupies  a  high  biological  priority.  In  necrotic  or
degenerating  cells microbody  structure  remains  relatively normal.  The  increase  in  micro-
bodies  induced by CPIB  is inhibited by chloramphenicol.  No increase  in microbodies  oc-
curred  in female  rats or  in  chickens,  guinea  pigs,  or  rabbits at  the  dosage  used  (0.25%  in
diet).  No  changes  in  microbodies  were  seen  in monkey  liver.  Catalase  activity  was  gen-
erally  parallel  to  the  numerical  response  in microbodies.  Additional  observations  suggest
that  the microbody  response  to CPIB is not related  to hepatomegaly  induced  by  this agent
but may be related  to the hypolipidemic  effect of CPIB, though hypolipidemia  per se  is not
a specific or sufficient cause  of microbody proliferation.
INTRODUCTION
Microbodies  constitute  a  distinct  class  of  cyto-
plasmic  organelles,  of  relatively  recent  morpho-
logical  and  biochemical  characterization,  in
hepatic  and  renal  cells  of  several  vertebrates
including man,  and in  the protozoan,  Tetrahymena
pyriformis  (1,  2).  De  Duve  and  his  coworkers
showed  that  these  organelles  possess  several
enzymes  capable  of production  and catabolism  of
hydrogen  peroxide  (3)  and  termed  them "peroxi-
somes"  to indicate their  biochemical potential  (4).
By electron  microscopy,  microbodies are identified
by several characteristics.  In the rodent  liver,  they
are  approximately  0.5  Ap  in  diameter,  circular  in
thin  sections,  limited  by  a  single  membrane,
contain  a  homogeneous  matrix  of  moderate
electron  opacity,  and  possess,  in  many  species,  a
nucleoid  or  core  of greater  density  than  the  sur-
rounding matrix.  The nucleoid  may  be absent or,
if  present,  either  of  a  highly  ordered  crystalline
pattern  or lacking  a  specific,  organized  structure.
In many  vertebrates,  the shape and ultrastructure
of  the  nucleoid  is  characteristic  of  and  constant
within the species  (5).' A number of morphological
variations  in  renal  microbodies  of  normal  rats
have been reported by Ericsson and Trump (6).
The role of microbodies in cell physiology is  not
known,  and  comparatively  little  attention  has
been  paid to their pathologic  reactions,  especially
in  species  other  than  rodents.  Morphologically,
these  organelles  appear  comparatively  unrespon-
sive  to most experimental conditions,  and, with few
exceptions  (7-12),  alterations in microbodies  have
been  reported infrequently  or only incidentally.
Recent  observations  (13,  14)  have  indicated
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Distribution of Rats for Electron Microscopic Study  of Clofibrate (CPIB) Effects  on Liver
Group  No.  and  sex  of  animals  Experimental  schedule  and  time  of  sacrifice
Basic experiment
Controls
1.  CPIB  (0.25%)  +  Purina chow
2.  CPIB  (0.1%)  +  Purina  Chow
3.  CPIB  (0.25%)  +  Purina  Chow
Reversal
4.  CPIB  (0.25%)  +  Purina Chow
5.  CPIB  (0.25%)  + Purina  Chow
Inhibition
6.  Chloramphenicol  (2%)  +  CPIB
(0.25%)
7.  Chloramphenicol  (2%)
8.  Aflatoxin  B 1 (0.45  mg/kg)  2X/wk
i.p.  +  CPIB  (0.25%)  +  Purina
Chow
9.  Aflatoxin  B  (0.45  mg/kg)  2X/wk
i.p.  +  Purina Chow
10.  Actinomycin  D  (8  g/kg)  3X/wk
i.p.  +  CPIB  (0.25%)
11.  Actinomycin  D  (10  g/kg)  3X/wk
i.p.  +  CPIB  (0.25%)
12.  Actinomycin D  (8 ,ug/kg) 3X/wk i.p.
13.  Actinomycin  D  (10  /ig/kg)  3X/wk
i.p.
Thrombogenic diet
14.  CPIB  (0.25%)  + Purina  Chow for 2
wk  followed  by  thrombogenic  diet
for 5  wk
15.  Thrombogenic  diet + CPIB  (0.25%)
16.  Thrombogenic  diet
12,  male  10  (4)*,  20  (4),  and 30  (4)  days
32, male  12  hr  (2); 3  (2),  10  (4),  14  (4),  20  (4),  and
30  (6)  days;  6  (2),  8  (4),  10  (2),  and  21
(2)  wk
4,  male  3  (2)  and  10  (2)  wk
6,  female  2  (2)  and  4  (4)  wk
10,  male  CPIB for4 wk followed by sacrifice at 1 (3),
2  (4),  and  3  (3)  wk  after withdrawal  of
CPIB
4,  male  CPIB for 8 wk followed by sacrifice at I (2)
and  2  (2)  wk  after withdrawal  of CPIB
2,  male  14  days  (2)
2,  male  14  days  (2)
10,  male  4  wk  (10)
4,  male  4  wk  (4)
4,  male  8 wk  (4)
4, male  8  wk  (4)
2,  male  4  wk  (2)
2,  male  4 wk  (2)
4,  male 3  wk  (4)
5,  male  4 wk  (5)
2,  male  4  wk  (2)
Regeneration
17.  CPIB  (0.25%)  +  Purina  Chow  15
days,  partial  hepatectomy  on  7th
day
Necrosis
18.  CPIB  (0.25%)  + Purina Chow 7 wk;
0.14 ml CCI4 i.p. at end of 7th wk
5,  male  Sacrificed  8 days after partial hepatectomy
(5)
6,  male  Sacrificed  24 hr after CC14  injection  (6)
*  Numbers  in  parenthesis  refer  to  number of  rats sacrificed
taken in group  1 at 8 and  10 wk and  in group 3  at 4 wk.
at  each  interval.  Samples  of kidney were
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number,  and  in  enzyme  content  after  the  admin-
istration  of  ethyl  -p  - chlorophenoxyisobutyrate
(clofibrate,  CPIB),  a  hypolipidemic  agent  which
lowers serum  cholesterol  and  triglycerides in  man
(15)  and  in  experimental  animals  (16,  17).  Our
initial  observations  suggested  that,  with  use  of
CPIB,  several  aspects of microbody  behavior  and
morphology could be investigated  in  a  systematic
fashion  during  experimental  conditions.  Accord-
ingly,  the  present  experiments  were  undertaken:
(a)  to  investigate  the  behavior  of microbodies  in
selected  conditions in an  attempt  to  relate,  where
possible,  their  pathological  responses  to  their
behavior  in  normal  cells;  (b)  to  examine  their
following composition:  alphacel,  6%; butterfat,  40%;
cholesterol,  5%;  choline  chloride,  0.2%;  propyl-
thiouracil,  0.3%;  salt  mixture,  4%;  sodium  cholate,
2%; sucrose,  20.5%;  vitamin  mixture,  2%; vitamin-
free casein, 20%.
To  compare  the  effects  of  CPIB  with  those  of
other hypolipidemic  agents,  male rats  of CFE strain,
weighing  between  100  and  140  g,  were  given  the
agents  listed in Table  II.
To discover  the species  range of response of hepatic
microbodies  to  CPIB,  we  studied  samples  of  liver
from  the  following  animals.  (a)  C 3H  male  mice
were  given 0.25%  CPIB in ground  Chow  diet.  Two
mice  were  killed  at  9,  11,  and  14  days;  four  were
killed at  1 month  and  5 months.  (b) Two  hamsters,
two  guinea  pigs,  and  two  rabbits  (all  males)  were
TABLE  II
Additional Hypolipidemic Agents Studied in Male CFE Rats
No.  of
Agent  Dose  Route  animals  Time  of sacrifice
1.  20,25-diazacholesterol  (SC-  0.25%  in diet  4  14  (2),  27  (2)
12937)  days
2.  Benzmalacene  0.4%  in diet  4  14  (2),  27  (2)
days
3.  Benzyl-N-benzyl  carbethoxy  2%  in diet  2  13  days
hydroxamate  (BNBC)
4.  Dextran  1 g/kg  i.p.  4  5  (2),  21  (2)  days
5.  Crystalline  bovine  catalase  (Ca-  25  mg of protein per  kg  i.p.  4  14  (2),  27  (2)
perase)  days
6.  2,4-dichlorophenoxyacetic  acid  0.125%  in diet  2  54  days
range  of morphologic  responses  in  experimental
conditions;  and  (c)  to  illustrate  their relationship
to other cytoplasmic  constituents,  particularlywith
regard  to  their  mode(s)  of origin  and  depletion.
Furthermore,  the  differences  in  microbody  re-
sponse to  CPIB in several  species was  studied  as a
preliminary attempt  to  clarify  the  relationship  of
the  microbody-inducing  effect  of CPIB  to  other
properties of this agent.
MATERIALS  AND  METHODS
Experiments on  Rat Liver with CPIB
For  electron  microscopic  study  of  rat  liver,  the
distribution  of  animals,  experimental  manipulations
and  time  when  killed  are indicated  in  Table  I.  All
rats  used  were  F-344,  weighing  between  126  and
262  g.  The  basal  diet  consisted  of  ground  Purina
Chow  to which  CPIB  was  added  prior  to  thorough
mechanical  mixing.  The  thrombogenic  diet  had  the
given  0.25%  CPIB  in  suitable  laboratory  diet  and
killed  at  14 days.  (c) Two  white  leghorn  cocks  were
fed  0.25%  CPIB  and  killed  at  3  wk.  (d) One  male
South  American  squirrel  monkey  (Saimiri  sciurea),
weighing  approximately  2  kg,  was  force-fed  CPIB
(75  mg/kg)  daily  and  killed  at  22  days.  (e)  One
male  mongrel  dog  was  given  CPIB  (25  mg/kg)
daily  and killed  at 26  days.  With  each species,  liver
from one  of two controls  was studied.
Light and Electron Microscopic  Methods
For light  microscopy,  samples  of tissue were  fixed
in  neutral  buffered  formaldehyde,  embedded  in
paraffin,  and  sections were  stained  with hematoxylin
and  eosin.  For  electron  microscopy,  tissues  were
fixed  for  1-2  hr  in  2%  osmium  tetroxide  buffered
with s-collidine  or in  phosphate-buffered  glutaralde-
hyde,  dehydrated  in a  graded  series  of  alcohols  and
embedded  in  epoxy  resin.  Thin  sections  were cut on
an LKB  8800A  ultramicrotome  equipped  with  glass
or  diamond  knives,  stained  with  lead  or  uranyl
acetate,  and examined in an RCA 3G electron micro-
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accelerating  voltage  of  50  kv.  For  orientation  of
blocks  prepared  for  electron  microscopy,  semi-thin
sections  (0.5  1.5  it)  were  stained  with  azure  A  in
sodium  bicarbonate  and  examined  by  light  micros-
copy.
Biochemical Methods
In groups  1, 4,  5,  and  7  through  11  (Table  I),  as
well  as  in  mice  on  CPIB  for  4  months,  samples  of
liver  were  taken  for  determination  of  catalase  and
uricase  activity.  Catalase  activity  was determined  by
the  spectrophotometric  method  described  by  Lick
(18),  using  a  24-hr  extraction.  Uricase  activity  was
assayed  according  to  the procedure  of  London  and
Hudson  (19).  Protein  was determined  by  the  Lowry
method  (20).  Determinations  of  enzyme  activity
were  done  in  duplicate.  For  total  liver  lipids  in
animals  fed  a  thromnbogenic  diet,  the  livers  were
dried  to  constant  weight,  extracted  with  ethanol-
ether  (3:1),  reweighed,  and  lipids  were  determined
by weight  difference.
RESULTS
Light Microscopy
In  hematoxylin  and  eosin  stained  sections  of
paraffin-embedded  liver  of male  rats treated  with
CPIB,  the  architecture  appeared  normal.  The
cells,  however,  were of greater than normal diam-
eter  and  this  increase  appeared  to  be  solely  the
result  of an  increase  in  cytoplasm.  In many  cells,
at  random  throughout  the  lobules,  cytoplasmic
basophilia  was decreased  and replaced  by eosino-
philic,  granular  areas.  In  osmium  tetroxide-fixed,
Epon-embedded  blocks  of  liver  stained  with
azure-bicarbonate  and  examined  with  orange  or
red  filters,  microbodies were  evident  as numerous
dark,  sharply  punctate  dots  which  were  denser,
smaller,  and  more  uniformly  circular  than  mito-
chondrial  contours  (Figs.  1-3).  Nuclei  and
nucleoli  appeared normal
Electron Microscopy
BASIC EXPERIMENT.  GROUPS  1, 2, AND  3
(TABLE  I)
GROUP  1:  No  changes  in  number  or  struc-
ture  of  microbodies  were  apparent  at  12  hr.
The  changes  in  male  liver  after  feeding  CPIB
for 3-30  days  consisted  of marked  increase  in  the
number  of microbodies,  first  apparent  at  3  days
and  sustained  thereafter  (Fig.  4).  A  large  propor-
tion  of  microbodies  were  abnormal  in  size  and
FIGURE  1  Normal  male  rat  liver.  Photomicrograph  of  OsO4-fixed,  Epon-embedded  sections  (1.0  A)
stained  with  azure-bicarbonate.  Moderate  numbers  of  microbodies  (arrows)  are  apparent.  (Photo-
graphed with red  filter.)  X 600.
130  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  35,  1967FIGURES  2 and 3  Male rat liver. CPIB,  20 days. Compared  to the normal  (Fig.  1),  the number of micro-
bodies  (arrows)  is  increased appreciably.  Microbodies  are round, dense,  and  distinct  (Fig.  3),  compared
with the mitochondria which  are faint and have indistinct  margins.  The increase  in microbodies  is appar-
ent throughout  the entire cytoplasm.  Although  microbodies  cannot be distinguished  unequivocally  from
lysosomes  or  peribiliary  dense  bodies  by  this technique,  the  generalized  increase  in  circular  densities
in  all parts  of the cytoplasm  (not limited  to peribiliary  areas), the absence  of detectable  increase  in the
number  of lysosomes  as shown  by  electron  microscopy  or  in  biochemical  determinations  of  acid  phos-
phatase  activity
4 as well as by comparison  to Fig.  4  (an electron  micrograph  taken from the same liver)
indicate  that most,  if  not all,  of the circular  densities  are  microbodies.  Fig.  2,  X  1000;  Fig.  3,  X  2000.
shape, their matrix contained  linear striations, and
many  lacked  nucleoids.  Variation  in  matrix
density  and  continuity  of  the  limiting  membrane
with  smooth  ergastoplasmic  membranes  were
frequently  seen. After 30 days, there was no further
increase  in number of microbodies  in  animals that
remained  on  CPIB,  although,  by  6  wk,  atypical
forms  appeared  to  be more  numerous  than previ-
ously (Figs.  5,  6).  In addition,  there was conspicu-
ous  increase  in  vesicles  of  smooth  endoplasmic
reticulum  (Fig.  7). At 8 wk, the  increased  number
of microbodies  as well  as  increased  smooth endo-
plasmic  reticulum  persisted.  Many  ill  defined
diffuse  densities,  not  clearly  limited  by  a  mem-
brane at their entire  periphery,  were present  (Fig.
8),  and  continuity of microbodies  with  vesicles  of
smooth  endoplasmic  reticulum  was  conspicuous
(Fig.  9).  Occasionally,  roughly rectangular  areas
with  the  density  of microbodies  were  connected
by narrow,  tubular channels  (Fig.  10).
At  10  wk,  there  were  many  small,  irregularly
shaped  structures  resembling  microbodies  in
density  (Fig.  11),  frequently  located  near  large,
more  nearly normal  microbodies.  Many lacked  a
limiting  membrane  about  their  entire periphery;
instead,  a  portion  of their matrix  was  disposed  as
a  diffuse,  ill  defined  density  in  the  hyaloplasm
(Figs.  11,  12).
At  all  intervals,  there  were  no  conspicuous  or
uniform  changes  in  mitochondria.  A  few  showed
elongation  and flattening  with close  apposition  of
limitingmembranes.  In others,  there  were  mem-
brane-limited  collections  of fibrils  (Fig.  13).
GROUP  2:  In  animals  fed  CPIB  at  a  lower
concentration  (0.1%)  in  the  diet,  there  was  no
apparent  increase  in  the  number  of microbodies
nor alterations  in  their structure  at  3  and  10  wk.
GROUP  3:  Female  F-344  rats  given  0.25%
CPIB  in  their diet  and  sacrificed  at 2  and 4  wk
showed  neither  an  increase  in  microbodies  nor
D.  SOBoDA,  H.  GRADY,  AND  D.  AZARNOFF  Microbodies  in  Altered Cells  131FIGuRE 4  Male rat liver. CPIB, 20 days. Numerous microbodies  (mb) are evenly distributed throughout
the cytoplasm.  While  most  do not  have  well  defined  nucleoids,  a few  contain  small eccentric  densities
(n).  Mitochondria  (mi)  are normal.  X  11,000.
132FIGURE  5  Male  rat liver.  CPIB,  6  wk.  In the center,  an unusual form of microbody  (nb)  is seen.  Near
the  end  of  the straplike  extension,  a  protuberant  density resembling  a nucleoid  (n) is  apparent.  Con-
tinuity with an agranular  vesicle  is seen  at the arrow.  X  66,000.
structural  abnormalities  in  these  organelles  al-
though  vesicles  of smooth  endoplasmic  reticulum
were  slightly increased.
GROUPS  4  AND  5;  REVERSAL
Microbodies  were  increased  in  number  to  the
same extent in rats given 0.25%  CPIB for  4 and 8
wk  (Table  I,  groups  4 and  5,  respectively).  At  I
wk after  withdrawal  of CPIB and restoration  to  a
normal  Chow  diet,  the  increase  persisted.  By  2
wk,  there appeared  to be a variable decrease  from
cell  to  cell  in the  number  of  microbodies.  Three
wk  after  restoration  to  a  normal  diet,  however,
liver  cells  appeared  normal  in  both  groups  with
respect to  microbodies  although vesicles  of smooth
endoplasmic  reticulum  were  relatively  abundant
(Fig.  14).
In rats restored  to  a normal  diet after  4 and  8
wk  on  CPIB  (groups  4  and  5),  and  to  a  lesser
extent  in those  maintained  on 0.25%  CPIB for  10
and  21  wk  (group  1),  there  was  segregation  of
microbodies  within  single  membrane-limited
cytoplasmic  structures  which  usually  contained
small  amounts  of  other  cytoplasmic  material
(Fig.  15).  Typically,  these  bodies  were  roughly
circular  with  an  average  diameter  of  0.5  ,
limited  by a single  membrane  and  containing,  in
addition  to  ergastoplasmic  membranes,  glycogen
and  ribosomes,  microbodies  possessing  charac-
teristic matrix density and, occasionally, a nucleoid
(Fig.  16).  Certain  structural  variations  were
apparent.  Interruptions in  the limiting membrane
(Fig.  17)  or the appearance  of multiple  encircling
membranes  as  a result  of the  close  apposition  of
collapsed  ergastoplasmic  membranes  to  the outer
contour  of  the  limiting  membrane  were  noted.
Frequently,  like  many  microbodies  free  in  the
cytoplasm,  the  captive  microbody  lacked  a
nucleoid.  The number of single membrane-limited
structures  containing  microbodies  in  any  given
section  of liver was  small.  Several  cells  had none.
D.  SVOBODA,  H.  GRADY,  AND  D.  AZARNOFF  Microbodies in  Altered Cells  133FIGURE  6  Male rat liver.  CPIB,  6  wk.  Two microbodies  (mb)  with  elongated  straplike  extensions  are
shown.  Numerous  polysomes  (p)  are  present.  X  28,800.
FIGURE  7  Male  rat  liver.  CPIB,  6  wk.  Extensive  areas throughout  the cytoplasm,  including  perinu-
clear  zones,  are  occupied  by  vesicles  of smooth  endoplasmic  reticulum  (SER).  X  28,800.
Inhibition of CPIB Effect  on Microbodies
Two  per  cent  chloramphenicol  in  the  diet
(group  6)  fed  concomitantly  inhibited  the  effect
of  CPIB  on  microbodies.  Sections  of  liver  from
CPIB-treated  rats  given  chloramphenicol  were
indistinguishable  from  those  of  liver  from  rats
given  chloramphenicol  only  (group  7);  the  most
conspicuous  abnormality  consisted  of  mitochon-
drial  enlargement  and  a  moderate  increase  in
smooth  endoplasmic  reticulum.
The  effect  of  aflatoxin  B  (0.45  mg/kg  intra-
peritoneally  twice  a  week for  4 wk)  on microbody
formation  in  CPIB-treated  rats  (groups  8  and  9)
was  not  as conclusive  as  that of chloramphenicol.
In most cells,  the number of microbodies appeared
normal,  but in some  there was an obvious increase
in  their  number.  Actinomycin  D,  in  a  dose  of 8
pg/kg  three  times  per week  for  8  wk  (group  10),
only partially inhibited  the  CPIB  effect  on micro-
bodies  and on  liver weight whereas  a higher  dose
(10  g/kg per  wk, group  11)  completely inhibited
the CPIB effect.
Thrombogenic Diet
In rats given a  thrombogenic  diet, there  was no
detectable  increase  in  microbodies  after  2  wk  of
CPIB  administration  followed  by  thrombogenic
diet  and  CPIB  for  1 wk  (group  14),  or  when
thrombogenic  diet  and  CPIB  were  administered
together for  1 month  (group  15).  In  both  groups
fed  thrombogenic  diet, however,  the large number
and  size  of  fat  vacuoles  rendered  quantitative
estimation of microbodies  difficult.
Regeneration
In  rats  given  CPIB  for  15  days,  subjected  to
partial  hepatectomy  on  the  7th  day  and killed  8
days  later  (group  17),  the  cells  of  regenerating
liver  contained  large  numbers  of  microbodies
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topographical  association  of microbodies  with  the
few  available  and  rudimentary  cisterns  of smooth
or  partially  granulated  strands  of  endoplasmic
reticulum was a prominent feature in regenerating
liver (Fig.  18).
Necrosis
In  rats  fed  CPIB  for  7  wk  and  given  carbon
tetrachloride  24  hr prior  to  sacrifice  (group  18),
there  were  extensive  dilatation  of  endoplasmic
reticulum  and cell  necrosis  but there was no  clear
cut  evidence  for  the  mechanism  of  disposal  or
destruction  of  microbodies  in  necrotic  cells.  In
cells  showing  extensive  nuclear  and  cytoplasmic
injury, especially involving endoplasmic reticulum,
microbody  structure  remained  relatively  intact
(Fig.  19).
Additional Hypolipidemic Agents
In  rats  given  SC-12937  (20,  25-diazacholes-
terol),  benzmalacene,  BNBC  (benzyl-N-benzyl
carbethoxy  hydroxamate),  dextran,  Caperase
(bovine  hepatocatalase),  or  2,4  - dichloro-
phenoxyacetic  acid,  there  was  no  discernible  in-
crease in number of microbodies nor abnormalities
in  their  structure.  After  certain  agents,  notably
BNBC,  there were conspicuous  amounts  of smooth
endoplasmic  reticulum.
Comparison of Species' Response to CPIB
At 9-14  days,  male  C 3H  mice given  0.25%  of
CPIB  showed  a slight  increase  in  hepatic  micro-
bodies and there was moderate  increase in vesicles
of smooth endoplasmic  reticulum. In serial sections
small  vesicles,  indistinguishable  from  smooth
endoplasmic  reticulum,  contained  deposits  of  a
density  similar  to  that  of  a  microbody  matrix
(Fig.  20).  Connections  of the limiting  membrane
of  microbodies  to  membranes  of  smooth  endo-
plasmic  reticulum  were  apparent.  From  1  to  5
months,  the increase  in  microbodies  was  uniform
in  all  cells examined  (Fig.  21),  but no  additional
changes  were observed.
FIGURE  8  Male rat  liver.  CPIB, 8  wk. In addition  to more  nearly typical  microbodies  (mb),  many ill
defined  diffuse  densities  (d),  lacking  a distinct limiting membrane,  are present.  X  72,000.
D.  SVOBODA,  H.  GRADY,  AND  D.  AZARNOFF  Microbodies in  Altered Cells  135FIGURE  9  Male  rat liver.  CPIB,  8  wk.  In  addition  to  a  microbody  (mb),  several  single  membrane-
limited,  roughly  circular  densities  (d)  with an electron opacity  similar to that  of microbodies  are appar-  .
ent. At the arrows, two  such densities are in continuity with a circular  loop of smooth endoplasmic  retic-
ulum.  X  66,000.
FIGURE  10  Male  rat liver.  CPIB, 8  wk.  Two  roughly rectangular  dense  areas  (d)  are  connected  by a
narrow channel (arrow).  X  66,000.
In  dogs  and  hamsters  the  number  of  micro-
bodies  appeared  increased  in  most  cells.  In  the
latter  species,  there  were  additional  structural
features  not  evident  in  other  groups.  While
moderate  structural  variation in  microbodies  was
apparent  in  normal  hamsters,  this  variation  was
markedly  accentuated  by  the  feeding  of  CPIB.
Microbodies  often  had  elongated  profiles  with
tail-like  extensions  (Figs.  22,  23)  or  a  bulbous
extension  giving  a  bipartite  appearance.  Oc-
casionally,  two  ovoid  portions  were  joined  by  a
tubular  connection.  In  those  cells  in  which  lipid
globules  were  present,  microbodies  were  closely
apposed  to the  periphery  of the globule  (Fig.  24).
In  the  livers  of guinea  pigs,  chickens,  rabbits,
and  squirrel  monkeys  there  were  no  detectable
changes  in  microbodies  at  the  dose  used but  the
amount  of  smooth  endoplasmic  reticulum  was
increased  to variable  degrees.  In Rhesus  monkeys
the hepatic  microbodies  commonly  have  a  small
nucleoid  or  none,2 but  in  squirrel  monkeys  they
contain  an  irregular  linear  or  angular  nucleoid
(Fig.  25).
Kidney
In rats,  at 8-10 wk,  renal  microbodies  were in-
creased  most  prominently  in  basal  portions  of
some proximal tubular epithelial  cells. In contrast
to  hepatic  microbodies,  most  renal  microbodies
contained  a  central  or  paracentral  faint  and  ill-
defined  density  resembling  a  nucleoid  (Fig.  26).
The  limiting  membrane  of  microbodies  was  fre-
2  D. Svoboda,  1966.  Unpublished  observations.
136  T  E  JOURNAL  OF  CELL  BIOLOGY  VOLUME  35,  1967FIGURES  11  and  12  Male  rat  liver.  CPIB,  10  wk.  In a  single  plane  of  section  are many areas  with  a
density  (d)  identical  with that  of microbodies,  which instead  of being  circular  and confined  throughout
their  periphery  by  a membrane,  appear  to have  diffuse  extensions  into the  hyaloplasm.  A  segment  of
the periphery  is,  however,  limited by a membrane  (m).  Fig.  11,  X  28,800;  Fig.  12,  X  118,000.
FIGURE  13  Male  rat  liver.  CPIB,  10 wk.  The  most conspicuous  mitochondrial  change  is the presence
of  membrane-limited  collections  of  fibrils  (f).  X  72,000.FIGURE  14  Male  rat liver.  CPIB, 8  wk,  followed  by  wk of  normal diet.  The liver cells  are  restored
to normal  with respect to the number of microbodies  (mb) although smooth endoplasmic reticulum (SER)
is still increased.  X  9600.
138  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  35,  1967FIGURE  15  Male  rat liver.  CPIB,  8 wk,  followed  by  I wk of restoration  to a normal diet.  A microbody
(mb)  is  present  within  a  single  membrane-limited  cytoplasmic  structure  which  also contains  glycogen
(g)  and vesicles  of endoplasmic  reticulum.  X  88,000.
FIGURE  16  Male rat liver.  CPIB,  8  wk,  followed  by I  wk  of restoration to a normal  diet.  A microbody
(mb)  with an eccentric, dense nucleoid  (n) is present within a single membrane-limited  structure. X 72,000.
quently  continuous  with  vesicles  of smooth  endo-
plasmic  reticulum.
Linear striations were not present in  the matrix
of renal  microbodies  nor  were  they  observed  in
hepatic microbodies  of any species other than rats.
They  were  not  apparent  in  microbodies  within
lysosomes.
Biochemical Results
The  results  of  the  determination  of  catalase
activity  in  livers of selected  groups of animals are
shown  in Tables  III  and IV.
In  general,  the  catalase  activity  corresponded
quite closely  to the increase  in microbodies  (Table
III). By  10-20 days of CPIB feeding,  the catalase
activity  was  elevated  but  did not continue  to  rise
thereafter;  at 30  days,  the  level  fell  slightly  from
that at  20 days.  Upon  removal  of CPIB  from the
diet  for  1, 2,  and  3  wk,  the  levels  of activity  fell
appreciably.  By 2 wk' reversal,  the catalase activity
was virtually  restored  to  normal.  The  lower  dose
of actinomycin  D alone inhibited  catalase activity
but  this  inhibition  was  markedly  offset  by  the
addition  of CPIB. With  the higher  dose of actino-
mycin D, on  the other hand,  the inhibitory effect
was only  partially  offset by the  administration  of
CPIB.  Inhibition  of catalase  activity by aflatoxin
B1 alone  was  not  so  marked  as  with  actinomycin
D  and  was significantly  reversed  by the  addition
of  CPIB.  Thrombogenic  diet,  by  itself,  lowered
the  catalase  activity  appreciably  and  addition  of
CPIB  before  or  during  the  hypercholesterolemic
state  produced  by  feeding  thrombogenic  diet did
not  increase  catalase  activity.  In  male  mice,
catalase  activity  increased  markedly  at  5  months
of feeding 0.25%  CPIB  (Table IV).
D.  SVoBODA,  H.  GRADY,  AND  D.  AZARNOFF  Microbodies  in  Altered Cells  139FIGURE  17  Male rat liver.  CPIB,  21  wk.  A  microbody  (mb)  with  an irregular  crescentic  profile  is en-
closed within  a single  remnibrane-limited  structure.  Within  the  Golgi  area  (gpa)  several  vesicles  (arrows)
have an  interior  density  resembling  that  of  microbodies  free  in  the  cytoplasm.  X  66,000.
Uricase  activity  followed  no  definite  pattern
and  showed  little  or  ro  correlation  with  liver
weight,  microbody  response,  or catalase  activity.
Results were so variable  as  to render  it impossible
to  make  meaningful  comparisons  even  among
related experimental groups.
Liver Weight
In  the  basic  experiment,  the liver weight,  ex-
pressed  as  per cent body weight, increased  signifi-
cantly in  animals given CPIB.  Hepatomegaly  was
apparent on gross inspection  and, microscopically,
appeared  to  be  primarily  due  to  an  increase  in
cell  size  although  the possibility  of some  increase
in  number  of cells  cannot  be  excluded  since  esti-
mation  of  DNA/g  wet  weight  of  liver  was  not
done. Removal  of CPIB from the diet was accom-
panied  by  significant  decrease  in  liver  weight  by
1 wk  and  further  decreases  with  near  restoration
to normal  after 2- and  3-wk  reversal.  In the  basic
experiment  and  reversal  groups  therefore,  the
liver  weights  were  roughly  parallel  to changes  in
catalase  activity (Table  III). In the  inhibition  ex-
periments,  there  was appreciable  increase  in liver
weight  of rats given  CPIB  plus  aflatoxin  B1 . With
actinomycin  D  alone,  no  increase  in  liver  weight
was noted but,  with the addition of CPIB to both
dose  levels  of  actinomycin,  the  liver  weight  in-
creased  appreciably.  Thrombogenic  diet  alone
was  accompanied  by  an  increase  in liver weight;
CPIB  given  concomitantly  caused  a  slightly
greater increase.
DISCUSSION
In  general,  few  changes  have  been  noted  in
hepatic  microbodies  in  most  pathological  con-
ditions,  but  Hruban  and  co-workers  have  de-
scribed  alterations  in  the  matrix  and  increase  in
number  and size  following  administration  of sali-
cylates,  enlargement  of the crystalloid  as  a  result
of azaserine  and  terephthalanilides,  and  extrusion
of  the  nucleoid  after  hexahydrosalicylic  acid  or
140  THE  JOURNAL  OF  CELL  BIOLOGY  · VOLUME 35,  1967FIGURE  18  Male rat liver.  Regeneration.  Numerous  microbodies  (mb), most of them  lacking a nucleoid,
are  present.  They  are  commonly  associated  with  narrow  cisterns  of  agranular  or  pratially  granulated
membranes of endoplasmic  reticulum  (arrows).  X  12,300.
sodium  tungstate  (19).  Dalton  (8)  suggested  that
the  number  of microbocdies  was  inversely  related
to  the growth  rate of hepatic  tumors.  Changes  in
the matrix of microbodies  after thioacetamide  (10)
and  numerical  increase  (21)  as  well  as  inhibition
(13)  after  ethionine  have  been  reported,  and
Confer  and  Stenger  (22)  demonstrated  that  in
hepatic  nodules  induced  in  mice  with  carbon
tetrachloride  the  microbodies  were  larger  than
normal  and  their  nucleoids  were  enlarged  and
more  complex.  Afzelius  (23)  and  Schnitka  (5)
showed quite consistent  species'  differences  related
to  the  presence  and  ultrastructure  of crystalloid
and  noncrystalloid  nucleoids  in  microbodies.
Tsukada  et  al.  (24)  isolated  nucleoids  from  rat
liver  and  showed  that  they  had  urate  oxidase
activity  380  times  higher  than  that  of the  whole
homogenate.  These  authors  suggested  that  in  rat
liver  the nucleoids  might be  the  only  cytoplasmic
particles  in which  urate  oxidase  is  located.  Simi-
larly,  de  Duve,  in  ultracentrifugal  studies  that
first  defined  the  chemical  composition  of  micIo-
bodies  (3),  reported  that  catalase  and  D-amino
acid  oxidase  were  probably  associated  with  the
matrix  of  rat  hepatic  microbodies  while  urate
oxidase  was  contained  in  the  nucleoid  or  in  the
membrane.  Verity  et  al.  (25)  found  that,  with
stepwise  purification  of mouse  liver homogenates,
the fraction  containing  microbodies had  a  20-fold
increase  in uricase  activity. While  the localization
of urate  oxidase  in  microbody  nucleoids  appears
consistent  in  several  instances,  certain  exceptions
occur. For example,  as pointed out by de Duve,  the
rat  kidney  lacks  urate  oxidase  even  though  the
renal microbodies  contain  amorphous  but distinct
central  densities  resembling  nucleoids  (6,  26).
(Fig.  26).  In  addition,  after  CPIB  many  of  the
newly formed hepatic microbodies lack a nucleoid,
and it  is clear  that  the presence  of a  nucleoid  is
not  necessarily  a  uniform  finding  in  rat  liver
microbodies  after  treatment  with  this  agent.
Similarly,  Biempica  (27)  showed that in a complex
D.  SVOBoDA,  H.  GRADY,  AND  D.  AZARNOFF  Microbodies in  Altered Cells  141FIGtlE  19  Male rat liver. CPIB,  7 wk.  Carbon tetrachloride  24 hr prior to sacrifice.  The endoplasinic  re-
ticulunm  (ER) is extensively  dilated and contains fibrillar  material. The internal structure  of mitochondria
(mi)  is  barely  discernible,  but the microbodies  (mb)  remain  comparatively  intact.  X  9600.
disease  state  many  microbodies  of  human  liver
acquired  crystalloid nucleoids.
While  the  hypolipidemic  effects  of  clofibrate
have been amply demonstrated  in vivo in man and
in  lower  animals,  the mechanism  of the  pharma-
cological  action  is not definitely established  at the
present time.  Platt and  Thorp  (28)  attributed  the
primary  effect  of  CPIB  to  displacement  of  thy-
roxine from  serum protein and proposed  that,  as a
consequence,  there  is  a  local,  high  concentration
of thyroxine  in the liver while  the whole  animal  is
relatively  hypothyroid.  In  this  context,  the
presence  of  propylthiouracil  (0.3 %)  in  the
thrombogenic  diet  may  render  untenable  the
present  ultrastructural  and  biochemical  observa-
tions  made  after  the  administration  of this  diet
since  this  concentration  of  an  antithyroid  drug
could,  theoretically,  interfere  with  the  proposed
pharmacological  action of CPIB. Moreover,  it was
considered  that the thrombogenic  diet, high  in fat,
might be unpalatable  to the rat and could account
for  a  low  consumption  of  this  diet  and  CPIB.
Though  food  intake  in  this  group  was  initially
below  the  average  of  control  rats,  after  3  days
the  consumption  of the  thrombogenic  diet,  with
and without  CPIB,  was normal.  The  entire  prob-
lem of the  relationship  of CPIB  to  thyroxine  and
microbody response is complex,  and related exper-
iments  will  be  dealt  with  in  greater  detail  in  a
separate  report.
3 According  to  the  proposal  of
Platt and coworkers  (29)  several  other  substances,
including  pyridoxal  phosphate  and  tryptophan,
are displaced from  plasma proteins  by CPIB and,
in  addition,  the  agent  causes  increase  in  weight
(30)  and protein content of rat liver with increase
in  smooth  endoplasmic  reticulum  demonstrated
in  the  present  experiments.  Osorio  et  al.  (31)
reported  increase  in  serum  glutamic  oxaloacetic
3  D.  Svoboda  and D.  Azarnoff,  1967.  The effects  of
CPIB  on  hepatic  microbodies,  catalase,  and  mito-
chondrial  function  in  thyroidectomized  rats.  In
preparation.
142  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  35,  1967FIGURE  20  Male  mouse  liver.  CPIB,  2  wk.  Many  small vesicles  of smooth  endoplasmic  reticulum,  in
the outlined  areas  of the cytoplasm,  contain electron-opaque  material identical  with that of microbodies.
The  limits of  some  of  the densities  are  indistinct.  X  17,000.
143FIGURE  21  Male  mouse  liver.  CPIB,  5  months.  Numerous  microbodies  (mb)  are  present  throughout
cytoplasm  of  two adjacent  cells.  The nucleoids  (n) are of highly  varied configurations.  X  1,300.
144FIGURE  22  Male hamster  liver.  CPIB,  2  wk.  A micro-
body  (mb)  with  an elongated  tail  is present  in a peri-
nuclear  location.  X  66,000.
transaminase  and glutamic pyruvate transaminase
in  man and in lower animals and related  this find-
ing to increase in lysosomal activity as reported  by
Paget  (32).  It  should  be noted,  however,  that  the
increase in number of lysosomes and the formation
of  "giant  lysosomes"  as  reported  by  Paget  is
difficult  to verify  from the illustrations.  Although
occasional lysosomes  containing  microbodies  were
evident  in  our  experiments,  these  were  rare  and
were  not accompanied by  any appreciable  degree
of focal  cytoplasmic  necrosis.  In  addition,  CPIB
administration  to rats  does not cause elevation  of
acid  phosphatase  activity  in  liver  homogenates.
4
Hepatomegaly  due to CPIB may not be strictly
related  to  the  microbody  response  or  to  changes
in  catalase  activity  induced  by this  agent.  In our
experiments,  liver  weight  had  returned  almost  to
normal  by  14  days  after  withdrawal  of CPIB  al-
4 D.  Azarnoff  and  D.  Svoboda,  1967.  Unpublished
observations.
FIGURE  23  Male  hamster  liver.  CPIB, 2  wk.  The
microbody  (mb)  contains  two  linear  densities  (d)
forming  an  elongated  nucleoid.  X  66,000.
though  microbodies  were  still  increased  to  an
appreciable  degree  in many  cells  at that interval.
Moreover,  in  female  rats,  liver  weight  increases
after 0.25%  CPIB  (28)  but there is  no increase  in
microbodies  in this  sex  at this  dose.  Similarly,  al-
though liver weight  in young  Rhesus monkeys  in-
creases  after  administration  of CPIB for  3 months
(28),  no  increase  in  the  number  of microbodies
occurs  in  a  related  species  (squirrel  monkey)  at
the  dose  used.  Actinomycin  D  (10  pug/kg  thrice
weekly)  given simultaneously  with  CPIB partially
inhibited  the  microbody  response  and  caused  a
decrease  in  catalase  activity  although liver weight
increased.  Admittedly,  the  comparison  of  liver
weight  to  catalase  activity  is  superficial,  since
several  other  factors  must  be  considered.  It  has
been  shown  previously  (28)  that  the  degree  of
change  in  liver  weight  as  a  result  of  CPIB  is
partially  dependent  on initial  weight  of the  ani-
mals.  Nevertheless,  a  general  trend  is  apparent
and comparison  of these parameters  seems valid  in
D.  SVOBODA,  H.  GRADY,  AND  D.  AZARNOFF  Microbodies in  Altered Cells  145FIGURE  24  Male  hamster liver.  CPIB,  2  wk.  Microbodies  (mb),  as  well  as mitochondria  (mi),  are  in
close apposition to large lipid vacuoles  (L).  X  28,800.
FIGURE 25  Squirrel monkey liver.  CPIB,  22  days. No  increase in number and no abnormality  in struc-
ture  of microbodies  are  noted  in this  species.  In contrast  to microbodies  of Rhesus  monkeys,  however,
the microbodies  of this  species  commonly  contain  irregular,  ill defined  nucleoids  (n).  X  28,800.
attempting a preliminary  delineation  of the phar-
macological effects  of CPIB and  their relationship
tomicrobodies,  catalase,  and liver weight.
The  numerical  assessment  of  the  microbody
population,  from  electron  micrographs,  bore  a
close  relationship  to  catalase  activity.  The  in-
creased  catalase  levels  most  likely  reflect  the  in-
creased  number of microbodies  since  70-80%  (3)
of catalase  is  located  in microbodies.  Accordingly,
it  would  be  expected  that  a  significant  elevation
in  catalase  activity  would  be  reflected,  in  large
part,  by  increase  in  size,  number,  and  density  of
the  microbodies.  From  two  different  approaches,
one biochemical  (3)  and the other by quantitative
assessments  from  electron  micrographs  (33),  it
has  been  estimated  that,  in  the  normal  rat  liver
cell,  there  are approximately  four times  as  many
mitochondria  as  microbodies.  In  the  present  ex-
periments,  quantitative  evaluation  of  electron
micrographs  and  comparison  of  the  number  of
mitochondria  to microbodies gave  a mitochondria
to  microbody  ratio  of  1:1,  an  absolute  increase
clearly  substantiated  in  semi-thin  sections  stained
with azure-bicarbonate.  The  microbody  response,
with  respect  to  both  the  increase  in  number  of
microbodies  and  increase  in  catalase  levels,
appears  to reach  a plateau  at around  30 days  and
levels  off  thereafter  despite  continued  CPIB  in
the  diet.  Though  variations  within  the  lobule  in
numbers  of  microbodies  have  been  shown  (7),
in the present experiments  a remarkable  uniform-
ity in  number  of microbodies  was  present  in  all
blocks  of liver  regardless  of their  position  in  the
lobule.  Though  many  microbodies  were  atypical
or  aberrant,  they  were  still  identifiable  either
by  the  typical  matrix  density,  size,  and  shape  or
146  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  35,  1967FIGURE  6  Male  rat  kidney.  CPIB,  10  wk.  The  microbodies  contain  indistinct  nucleoids  (n)  in  the
matrix.  X 1,300.
by  the  presence  of  matrix  striations.  Novikoff
and  Shin  (7)  pointed out earlier  that,  even  when
the  plane  of  section  does  not  pass  through  the
cores, microbodies  are identifiable  by size,  shape,
or  degree  of electron  opacity.  While  one  or  two
structural  features  were  absent  in some  instances,
the  possession  of  the  remaining  characteristics
served to  identify  the  organelles  with  reasonable
certainty.
Relationship of Microbodies 
to Other
Cell  Organelles
Ericsson  and  Trump  (6)  and  Ericsson  (26)
reported  continuity  of the limiting membrane  of
microbodies  with  smooth  endoplasmic  reticulum
in  the kidney,  and  several  authors  (1,  7,  11,  34)
have  shown  continuity  between  microbodies  and
smooth  endoplasmic  reticulum  in  normal  and
pathological  rat liver. In the kidney, Ericsson  (26)
reported  a close  relationship  of microbodies to  the
Golgi  apparatus.  In  the present  experiments,  not
only were microbody attachments to smooth endo-
plasmic  reticulum  prominent  in  liver  and kidney
of the  rat, but  in  liver  of the mouse  densities  in
dilated  cisterns  of smooth  endoplasmic  reticulum
strongly suggested  formation  of microbody matrix
material  in  specialized  portions  of smooth  endo-
plasmic  reticulum  (Fig.  24).  In  the regenerating
liver,  too,  there  was  remarkably  close  apposition
of microbodies to elongated profiles of incompletely
granulated  endoplasmic  reticulum.
In addition  to  the topographical  and  biochem-
ical  (35,  36)  association  of microbodies  to ergasto-
plasm,  under  certain  circumstances  microbodies
are  intimately  related  to  lysosomes.  After  long-
term administration  of CPIB  or  after withdrawal
of CPIB, microbodies are incorporated,  along with
other  cellular  materials,  into  single  membrane-
limited bodies  resembling lysosomes  (Figs.  16-19).
Bruni and  Porter  (37)  suggested  that microbodies
were  disposed  of  by  fusion  with  lysosomes,  but
Novikoff  and  Shin  (7)  found  no  evidence  of
formation  of  intermediate  forms,  and  de  Duve
pointed  out that  "no  convincing image  of  fusion
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Changes in Catalase Activity  and Liver Weight  in  F344 Male Rats
No.  of  Liver  Units  catalase/
Group  animals  weight  mg  of protein
g/100 g  mean  i  standard
body  weight  error
Basic experiment
Controls
CPIB + Purina  Chow,  10  days
CPIB +  Purina Chow,  20  days
CPIB +  Purina Chow,  30  days
Reversal
CPIB +  Purina  Chow,  30 days
(a)  Reversed  I wk
(b)  Reversed  2  wk
(c)  Reversed  3  wk
Inhibition
Aflatoxin  B1 (0.45  mg/kg)  2X/wk  i.p.  CPIB
(0.25%)  +  Purina  Chow
Aflatoxin  B  (0.45 mg/kg)  2X/wk  i.p.  +  Purina
Chow
Actinomycin  D  (8 ,ug/kg)  3X/wk  i.p.  +  CPIB, 8
wk
Actinomycin  D  (10 ,ug/kg)  3X/wk  i.p.  +  CPIB,
8  wk
Actinomycin D  (8 ,ug/kg) 3X/wk  i.p.
Actinomycin  D  (10 /g/kg)  3X/wk  i.p.
Thrombogenic Diet
*Thrombogenic  diet +  CPIB  (0.25%)  4 wk
CPIB  (0.25%)  +  Purina  Chow for 2  wk  followed
by  thrombogenic  diet,  1 wk
IThrombogenic  diet
* Liver lipids,  239.5  mg/g.
t  Liver lipids,  251.9 mg/g.
5  3.6  53  4-  1.2
4  5.9  87  - 7.2
4  5.2  954- 6.4
4  6.0  82 %, 3.3
3  4.3  65  - 3.9
3  3.7  56  - 4.6
3  3.5  57  4-  2.8
<0.005
<0.001
<0.001
<0.02  >0.01
<0.5
<0.1
10  5.7  66  4  2.7  <0.01
4  3.8  44  4-  1.4  <0.01
4  4.4  78  4-  6.3  <0.005
4  5.4  38  - 2.2  <0.001
4  3.3  27  i  2.1  <0.001
4  3.4  26 4-  1.1  <0.001
4  8.5  37  4-  0.8  <0.001
4  5.0  27  +  3.7  <0.001
4  7.1  24  <0.001
TABLE  IV
Changes in Catalase Activity  in Male Mice
Units catalase/mg
Group  No.  of  animals  of  protein  P  value
mean  a  standard error
Controls  5  16  4  0.38
CPIB +  Purina Chow  (0.25%)  4  48  2.08  <0.001
of microbodies  is  shown;  neither  has  the  typical
structure  of  the  microbody  core  been  detected
within  a lysosome"  (4).  Similarly,  in  the kidney,
no  transition  forms  were  observed  (6).  While  no
evidence  of fusion  of microbodies  with  lysosomes
was  found  in  the  present  experiments,  micro-
bodies  with  a  core  or  nucleoid  were  present
occasionally in lysosomes (Fig.  16).  On the basis  of
quantitative  estimates  from  numerous  micro-
graphs,  however,  it would  appear  that the occur-
rence  of microbodies  in  lysosomes  is  too  rare  to
account  entirely for  disposal  of the  excess  micro-
bodies  in  this manner,  particularly  between  the
2nd and 3rd week after withdrawal  of CPIB when
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P  valuethe  number  of  hepatic  microbodies  is  restored
rapidly  to  normal.  The  structural  concept  of
"focal  cytoplasmic  degradation"  has  been  pro-
posed to explain the removal of certain cytoplasmic
constituents in  the  face  of injury or adaptation  to
an  altered  metabolic  state  (38).  When  one  con-
siders  the  occasional  presence  of  microbodies
within  single  membrane-limited  structures,  as
observed  in  the present  study,  it  seems  probable
that  at  least  one  mechanism  for  removal  or
digestion  of  microbodies  is  their  incorporation
into  lysosomes.  Presumably,  microbodies  seg-
regated  in  this  fashion  are  then  hydrolyzed  or
incorporated  into  a  residual  body  (38-40).
Alternatively,  it is possible that destruction of most
microbodies  is  accomplished  by  relatively  rapid
dissolution  into  the  hyaloplasm,  leaving  no
morphological "footprint"  of their prior existence.
Biochemical Results
Several  reviews  have  indicated  numerous
variables  which  influence  catalase  activity  and
have noted the  lack of uniformity in assay methods
and  in  expression  of  results  of  catalase  assays
(41-43).  Nonetheless,  under controlled  conditions
and  uniform  method  of  assay,  catalase  activity
generally  was  related  to  the  number  of  micro-
bodies  in  the  same  tissue  when  examined  by
electron microscopy.  In contrast,  uricase  activity
in  the present experiments  did  not correspond  to
numerical  changes  in  microbodies.  In  rats  on
CPIB  for  10,  20,  and  30 days,  uricase  levels  de-
creased  slightly,  but  the  decrease  was  not signifi-
cant and  might be interpreted  as a dilution  effect
due  to the enlargement  of the liver.  In mice,  the
drop  in  uricase  after  CPIB  for  5  months  was
slightly over 50%.
Species and Sex Differences
Most ultrastructural  observations of microbodies
have been  made  in  rodents,  but  Schnitka  (5),  in
several  additional  species,  has  illustrated  precise
differences  in size,  shape,  and  location  of micro-
bodies  and  to  the  presence  and  ultrastructure  of
the  nucleoid.  Similar  species  differences  in  the
response  of  hepatic  microbodies  to  CPIB  are
apparent from the present studies.
The  absence  of response  in  female  rats  to  the
dose  of  CPIB given  in these  experiments  may be
related  to  the natural  difference  of catalase  levels
in normal  rodents  (41,  44),  in  which males have
higher levels  in kidney and liver  than females  do.
In  the  dog,  CPIB  causes  an  increase  in  liver
weight  in  both  sexes  (28)  but  has  no  choleretic
action  (15),  and  in perfusion  experiments  there is
no penetration  of  CPIB  into  dog  liver  cells.  Yet
microbodies  increase conspicuously  in  this species,
suggesting  that the  entry  of  CPIB  into  cells  and
the  observed  effects  on  microbodies  may  not  be
related  phenomena  On  the  other  hand,  in  most
species which show a hypolipidemic  effect of CPIB,
there  is  a  concomitant  response  in  microbodies.
Although  our  earlier  tentative  interpretations
(14)  supported  the  hypothesis  of  Noviko-T  and
Shin  (7)  that  microbodies  were  in  some  way
related to lipid metabolism,  in the present  experi-
ments  other  hypolidemic  agents,  notably  2,4-
dichlorophenoxyacetic  acid,  which  is  structurally
closely related  to CPIB,  did  not cause increase  in
hepatic microbodies.  It is apparent, therefore,  that
although  in  the  case  of CPIB  the  hypolipidemic
effect may be related to microbodies, drug-induced
hypolipidemia,  in itself, is not a specific, sufficient,
or  general  cause  of increase  in microbodies.
Afzelius  (23)  has  reported that,  in Rhesus mon-
keys,  the  presence  or  absence  of a  nucleoid  had
not  been  established.  Whereas  we  found  only
rare  nucleoids  in  microbodies  in  Rhesus  mon-
keys,
2 in  the  squirrel  monkey  (Saimiri  sciurea)
irregular  and  indistinct  nucleoids  are  frequently
present.  Moreover,  in  this species the microbodies
are  topographically  associated  with  indentations
of  rough  endoplasmic  reticulum.  In  CPIB-
treated  animals,  the microbody  nucleoids  do  not
appear  to  change in this  species.  It is thus appar-
ent  that variation  occurs  in  different  genera  be-
longing  to different superfamilies  in  the same sub-
order  of mammals.
Regeneration
In regenerating  liver the  microbodies  were  in-
creased  to  a  degree  comparable  to  that  in  rats
given  CPIB without partial  hepatectomy,  and the
increase  was  similarly  apparent  in  the  entire
lobule.  Many of the cytological events accompany-
ing liver regeneration  and cell  division  in  general
have been reviewed previously  (45). In the context
of  the  present  experiments,  it  is  apparent  that
regenerating  cells  are  capable,  to  a  degree  com-
parable  to  nonregenerating  cells,  of  producing
microbodies  in response to CPIB and that produc-
tion of microbodies  has  a  high biological  priority
in rapidly  dividing cells.  Similarly,  in fetal mouse
liver,  it  has  been  reported  that  microbodies  are
the first single membrane-limited  bodies  to appear
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only  single  membrane-limited  bodies  in  prenatal
life  (46).  In  other conditions  involving  rapid  cell
division,  such  as  neoplasia  (8),  the  degree  of
microbody  formation may be quite variable.
Cell Degeneration
In rats given carbon tetrachloride, the liver cells,
by  light  microscopy,  showed  hydropic  degenera-
tion  and,  by electron  microscopy,  marked  dilata-
tion  of  the  endoplasmic  reticulum  along  with
obliteration  of most of  the  typical ultrastructural
features  of mitochondria.  Despite  these  changes,
however,  the  microbodies  remained  structurally
intact.  This  is  in  accordance  with  de Duve's  ob-
servations  regarding  the comparative  stability  of
the limiting  membranes  of microbodies  (4).
Inhibition of Microbody Proliferation
From the present  experiments,  it is  evident that
slight  differences  in  doses  of actinomycin  D  have
markedly  different  effects  on  the  catalase/micro-
body  response  to  CPIB.  Chloramphenicol,  which
inhibits  protein  synthesis  (47),  abolished  com-
pletely  the  microbody  response  to  CPIB.  When
one  considers  the  fact  that  chloramphenicol
inhibits  protein  synthesis  by  interfering  with  the
growth  of  the  nascent  polypeptide  chain  (48)
(though  interference  with  protein  synthesis  at  a
more  proximal  step  cannot  be  excluded  at  the
present time)  and  the data of Higashi  and  Peters
(35,  36)  that  indicate  that  catalase  is  first  syn-
thesized  in  the  granular  endoplasmic  reticulum
before  concentration  in  microbodies,  one  would
expect  interruption  of  ribosomal  function  by
chloramphenicol  to  result  in  aberrations  in
catalase  synthesis and, consequently,  in microbody
formation.  The  observation  that  CPIB  given
simultaneously  with  a  hypercholesterolemic
thrombogenic  diet  fails  to  induce  an  appreciable
increase  in  microbodies  suggests  that  hyper-
lipidemia  and  increased  liver  fat  inhibits  or
prevents  the  typical  increase  in  hepatic  micro-
bodies  due  to  CPIB.  As  previously  indicated,
however,  the  propylthiouracil  present  in  the
thrombogenic  diet  may  be  of  importance  in
mitigating  or  opposing  the  effect  of  CPIB.  In
addition,  since  ordinarily  the  microbodies  are
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